股票 › PHR
Phreesia医疗支付 PHR
美股市值排名 #3381
$12.62 −$0.09 (-0.71%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $12.62 0.00%
开盘$12.54
昨收$12.71
当日区间$12.27 – $12.64
成交量650.3K
市值$783.34M
市盈率（TTM）70.1
股息率–
PHR 相关新闻
匹配 Phreesia 或代码 PHR 的头条新闻，按最新排序。
- Raymond James Downgrades Phreesia(PHR.US) to Hold Rating, Cuts Target Price to $12 负面
- D.A. Davidson Maintains Phreesia(PHR.US) With Buy Rating, Cuts Target Price to $13 负面
- D.A. Davidson Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $13
- A Quick Look at Today's Ratings for Phreesia(PHR.US), With a Forecast Between $14 to $19
- Truist Financial Maintains Phreesia(PHR.US) With Hold Rating
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)
- JMDC: JMDC has confirmed that the practice of recording measurements from body composition analyzers and blood pressure monitors in a personal health record (PHR) may contribute to improvements in body weight and blood pressure. 正面
- Needham Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $14
- Alfresa Holdings: We are conducting a demonstration project to improve dietary habits through product recommendations and health support leveraging PHR data, with the aim of extending the healthy life expectancy of Tsukuba City residents and preventing lifestyle-related diseases.
- CCORF Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $16
- JMDC: Mitsubishi UFJ Bank, Omron, and JMDC are collaborating to promote regular blood pressure monitoring among all approximately 30,000 employees—leveraging PHR (Personal Health Record) technology to advance both self-care and advanced health management. 正面
- J.P. Morgan Maintains Phreesia(PHR.US) With Hold Rating, Maintains Target Price $14
- BMO Capital Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $14
- Barclays Maintains Phreesia(PHR.US) With Hold Rating, Maintains Target Price $10
- Tecmira Holdings: Wellmira and Arteryex have demonstrated the effectiveness of multidisciplinary collaboration leveraging PHR.
暂无评论——快来第一个聊聊 PHR。
登录后参与讨论。